Ultra-small quercetin-based nanotherapeutics ameliorate acute liver failure by combatting inflammation/cellular senescence cycle
2025

Quercetin-Fe Nanoparticles Help Treat Acute Liver Failure

publication 10 minutes Evidence: high

Author Information

Author(s): Feng Yali, Zhang Xiaoli, Li Juan, Fu Shan, Xu Weicheng, Liu Jinfeng, Yang Yuan, Chen Tianyan, Zhao Yingren, Li Dongmin, Zhang Mingzhen, He Yingli

Primary Institution: Xi'an Jiaotong University

Hypothesis

Can quercetin-based nanoparticles effectively reduce inflammation and cellular senescence in acute liver failure?

Conclusion

Quercetin-Fe nanoparticles significantly protect against acute liver failure by reducing inflammation and cellular senescence.

Supporting Evidence

  • QFN showed improved water solubility and ROS-scavenging properties.
  • QFN reduced inflammation and cellular senescence in vitro.
  • QFN significantly lowered ALT and AST levels in ALF mice.
  • QFN treatment promoted liver regeneration in ALF models.
  • Transcriptomic analysis revealed modulation of senescence and inflammatory pathways.

Takeaway

Researchers created tiny particles from quercetin and iron that help the liver heal by fighting inflammation and aging cells.

Methodology

The study synthesized quercetin-Fe nanoparticles and tested their effects on inflammation and cellular senescence in vitro and in a mouse model of acute liver failure.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.7150/thno.103746

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication